Patterns of wnt/Fzd/LRP gene expression during embryonic hematopoiesis

Stem Cells and Development

Volumn 18, Issue 5, 2009, Pages 759-771

  Corrigan, Pamela M ^a   Dobbin, Edwina ^a   Freeburn, Robin W ^a   Wheadon, Helen ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; WNT PROTEIN; WNT3 PROTEIN; WNT5A PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; FZD4 GENE; GENE; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; WNT 10B GENE; WNT 16 GENE; WNT 6 GENE; WNT 7B GENE; WNT 8A GENE;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; FRIZZLED RECEPTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIESIS; LDL-RECEPTOR RELATED PROTEINS; MICE; SWINE; WNT PROTEINS;

EID: 66249120015     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0270     Document Type: Article

References (53)

1. Dzierzak E. (2003). Ontogenic emergence of definitive hemato-poietic stem cells. Cur Opin Hem 10:229-234.
2. Dzierzak E and NA Speck (2008). Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat Immunol 9:129-136.
3. Taoudi S, C Gonneau, K Moore, JM Sheridan, CC Blackburn, E Taylor and A Medvinsky. (2008). Extensive hematopoietic stem cell generation in the AGM region via maturation of VE-cadherin+CD45+ pre-definitive HSCs. Cell Stem Cell 3:99-108.
4. Samokhvalov IM, NI Samokhvalova and S Nishikawa. (2007). Cell tracing shows the contribution of the yolk sac to adult hae-matopoiesis. Nature 446:1056-1061.
5. Keller G, M Kennedy, T Papayannopoulou and MV Wiles. (1993). Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 13:473-486.
6. Keller G, G Lacaud and S Robertson. (1999). Development of the haemopoietic system in the mouse. Exp Hem 27:777-787.
7. Smith AG. (2001). Embryo-derived stem cells: of mice and men. Ann Rev Cell Dev Biol 17:435-462.
8. Kennedy M, SL D'Souza, M Lynch-Kattman, S Schwantz and G Keller. (2007). Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109: 2679-2687.
9. Fehling H-J, G Lacaud, A Kubo, M Kennedy, S Robertson, G Keller and V Kouskoff. (2003). Tracking mesoderm induction and its specif cation to the haemangioblast during embryonic stem cell differentiation. Dev 130:4217-4227.
10. Palis J, S Robertson, M Kennedy, C Wall and G Keller. (1999). Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Dev 126:5073-5084.
11. Logan C and R Nusse. (2004). The Wnt signalling pathway in development and disease. Ann Rev Cell Devl Biol 20:781-810.
12. Nusse R. (2005). Wnt signalling in disease and development. Cell Res 15:28-32.
13. Dale TC. (1998). Signal transduction by the Wnt family of ligands. Biochem J 329:209-223.
14. Papkoff J and B Schryver. (1990). Secreted int-1 protein is associated with the cell surface. Mol Cell Biol 10:2723-2730.
15. Van Den Berg D, A Sharma, E Bruno and R Hoffman. (1998). Role of members of the Wnt gene family in human haemopoiesis. Blood 92:3189-3202.
16. Austin T, G Solar, F Ziegler, L Liem and W Matthews. (1997). A role for the Wnt gene family in haematopoiesis: expansion of multilineage progenitor cells. Blood 89:3624-3635.
17. Reya T, A Duncan, L Ailles, J Domen, D Scherer, K Willert, L Hintz, R Nusse and I Weissman. (2003). A role for Wnt signalling in the self-renewal of haemopoietic stem cells. Nature 423:409-414.
18. Willert K, J Brown, E Danenberg, A Duncan, I Weismann, T Reya, J Yates and Nusse R. (2003). Wnt proteins are lipid modified and can act as stem cell growth factors. Nature 423:448-452.
19. Müller-Tidow C, B Steffen, T Cuavet, L Tickenbrock, Ji P Diederichs, S Sargin, G Kohler, M Stelljes, E Puccetti, M Ruthardt, S deVos, S Hiebert, P Koeff er, W Berdel and H Serve. (2004). Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in haematopoietic cells. Mol Cell Biol 24:2890-2904.
20. Derksen P, E Tjin, H Meijer, M Klok, H Mac Gillavry, M van Oers, H Lokhorst, A Bloen, H Clevers, R Nusse, R van der Neut, M Spaargaren and S Pals. (2004). Illegitimate Wnt signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci USA 101:6122-6127.
21. Lu D, Y Zhao, R Tawatao, H Cottam, M Sen, L Leoni, Kipps, M Corr and D Carson. (2004). Activation of the Wnt signalling pathway in chronic lymphocytic leukaemia. Proc Natl Acad Sci USA 101:3118-3123.
22. Medvinsky A and E Dzierzak. (1996). Def nitive hemato-poiesis is autonomously initiated by the AGM region. Cell 86:897-906.
23. Andres B, P Gonzalo, S Minguet, J Martinez-Marin, P Soro, M Marcos and M Gaspar. (2002). The first 3 days of B-cell development in the mouse embryo. Blood 100:4074-4081.
24. Wheadon H and M Welham. (2003). The coupling of Tel/ PDGfbetaR to distinct functional responses is modulated by the presence of cytokine:involvement of mitogen-activated protein kinases. Blood 102:1480-1489.
25. Murray CE and Keller G. (2008). Differentiation of embryonic stem cells to clinically relevant populations:lessons from embryonic development. Cell 132:661-680.
26. Sasaki K, H Iwatsuki, M Suda and C Itano. (1993). Cell death and phagocytosis of haematopoietic elements at the onset of haematopoiesis in the mouse spleen: an ultrastructural study. J Anat 183:113-120.
27. Wolber F, E Leonard, S Michael, C Orschell-Traycoff, M Yoder and E Srour. (2002). Roles of spleen and liver in development of the murine hematopoietic system. Exp Hem 30:1010-1019.
28. Hao J, TG Li, X Qi, DF Zhao and GQ Zhao. (2006). WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev Biol 290:81-91.
29. Sato N, M Meijer, L Skaltsounis, P Greengard and A Brivanlou. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signalling by a pharmacological GSK-3 specific inhibitor. Nat Med 10:1:55-63.
30. Singla DK, DJ Schneider, MM LeWinter and BE Sobel. (2006). Wnt3a but not wnt11 supports self-renewal of embryonic stem cells. Biochem Biophys Res Commun 345:789-795.
31. Ogawa K, R Nishinakamaura, Y Iwamatsu, D Shimosato and H Niwa. (2006). Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem Biophys Res Commun 343:159-166.
32. Kouskoff V, G Lacaud, S Schwantz, H.J Fehling and G Keller. (2005). Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci USA 102:13170-13175.
33. Lindsley RC, JG Gill, M Kyba, TL Murphy and KM Murphy. (2006). Canonical Wnt signalling is required for development of embryonic stem cell-derived mesoderm. Dev 133:3787-3796.
34. Wang H, JB Gilner, VL Bautch, DZ Wang, BJ Wainwright, SL Kirby and C Patterson. (2007). Wnt2 coordinates the commitment of mesoderm to hematopoietic, endothelial, and cardiac lineages in embryoid bodies. J Biol Chem 282:782-791.
35. Lako M, S Lindsay, J Lincoln, PM Cairns, L Armstrong and N Hole. (2001). Characterisation of Wnt gene expression during the differentiation of murine embryonic stem cells in vitro: role of Wnt3 in enhancing haematopoietic differentiation. Mech Dev 103:49-59.
36. McWhirter J, S Neuteboom, E Wancewicz, B Monia, J Downing and C Murre. (1999). Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel Wnt gene in pre-B acute lymphoblastoid leukaemia. Proc Natl Acad Sci USA 96:11464 -11469.
37. Mazieres J, L You, B He, Z Xu, A Lee, I Mikami, F McCormick and D Jablons. (2005). Inhibition of Wnt16 in human acute lym-phoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene 24:5396-5400.
38. Dosen G, E Tenstad, M Nygren, H Stubberud, S Funderud and E Rian. (2006). Wnt expression and canonical Wnt signalling in human bone marrow B lymphopoiesis. MBC Immunol 7:1-17.
39. Muschen M, S Lee, G Zhou, N Feldhahn, VS Barath, J Chen, C Moers, M Kronke, JD Rowley, SM Wang. (2002). Molecular portraits of B cell lineage commitment. Proc Natl Acad Sci USA 99:10014-10019.
40. Zeng G, F Awan, W Otruba, P Muller, U Apte, X Tan, C Gandhi, AJ Demetris and SP Monga. (20 07). Wnt'er in liver: expression of Wnt and frizzled genes in mouse. Hepatology 45:195-204.
41. Liang H, Q Chan, A Coles, S Anderson, G Pihan, A Bradley, R Gerstein, R Jurecic and S Jones. (2003). Wnt5a inhibits B cell proliferation and functions as a tumour suppressor in haemopoietic tissue. Cancer Cell 5:349-360.
42. Mikels AJ and R Nusse. (2006). Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 4:e115.
43. Ishitani T, S Kishida, J Hyodo-Miura, N Ueno, J Yasuda, M Waterman, H Shibuya, R.T Moon, J Ninomiya-Tsuji and Matsumoto K. (2003). The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23:131-139.
44. Bone H and M Welham. (2007). Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis. J Cell Sci 120:1752-1762.
45. Yamaguchi T, S Takada, Y Yoshikawa, N Wu and A McMahon. (1999). T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification. Genes Dev 13:3185-3190.
46. Arnold S, J Stappert, A Bauer, A Kispert, B Herrmann and R Kemler. (2000). Brachyury is a target gene of the Wnt/β-catenin signalling pathway. Mech Dev 91:249-258.
47. Nostro MC, X Cheng, GM Keller and P Gadue. (2008). Wnt, activin, and BMP signalling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2:60-71.
48. Gadue P, TL Huber, MC Nostro, S Kattman and GM Keller. (2005). Germ layer induction from embryonic stem cells. Exp Hem 33:955-964.
49. Lacaud G, G Keller and V Kouskoff. (2004). Tracking meso-derm formation and specif cation to the hemangioblast in vitro. Trends in Card Med 14:314-317.
50. Ema H and H Nakauchi. (2000). Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood 95:2284-2288.
51. Nikolova T, M Wu, K Brumbarov, R Alt, H Opitz, KR Boheler, M Cross, AM Wobus. (2007). Wnt-conditioned media differentially affect the proliferation and differentiation of cord-blood-derived CD133+ cells in vitro. Differentiation 75:100-111.
52. Nemeth MJ, SM Anderson, Y Yang and DM Bodine. (2007). Wnt5a inhibits canonical Wnt signalling in hematopoietic stem cells and enhances repopulation. Proc Natl Acad Sci USA 104:15436-15441.
53. Roman-Gomez J, A Jimenez-Velasco, L Cordeu, A Vilas-Zornoza, E San Jose-Eneriz, L Garate, JA Castillejo, V Martin, F Prosper, A Heiniger, A Torres, X Agirre. (2007). Wnt5a, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia. Eur J Cancer 43:2736-2746.